InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,867.60
(
-0.80%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.28
(
0.07%
)
Bitcoin
64,287.05
(
0.01%
)
Post# of 353137
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

NYC Trader

Send PM Follow Ignore
Followers 1084
Posts 142881
Boards Moderated 5
Alias Born 01/25/2009

NYC Trader

Re: None

Thursday, 01/29/2015 10:11:41 AM

Thursday, January 29, 2015 10:11:41 AM

Post# of 353137
PMCB PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live cell encapsulation technology, Cell-in-a-Box(R), today announced that well-known scientific journalist, Vicki Brower, who writes for the leading top-tier cancer journals, has published an article naming PharmaCyte Biotech's pancreatic cancer treatment as a near-term approach to tackling the rising pancreatic cancer rates.

Visit my board"NY Penny Stock Exchange" for today's pick at http://investorshub.advfn.com/boards/board.aspx?board_id=16752

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up